iQue® Advanced Flow Cytometry Platform

📍 Albuquerque, United States🗓 Founded 2006👥 16 employees💰 Last funded 2013
Biotechnology🌐 sartorius.com
Website LinkedIn
At iQue® (formerly Intellicyt), our mission is to enable bioscience enterprises to rapidly and cost effectively screen and profile disease- and physiologically-relevant model systems for phenotypic endpoints using cell-based and/or bead-based assays. We do this by providing easy-to-use hardware, software, and reagent systems that are optimized to conserve precious samples, use less reagent, and to minimize time-to-answer to both enhance workflow productivity and to preserve the biology of interest. All major pharmaceutical companies and many biotechnology companies and academic institutions have invested in iQue® Advanced Flow Cytometry Platform solutions, to give their cell-based screening campaigns the edge.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2006
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in iQue® Advanced Flow Cytometry Platform?
iQue® Advanced Flow Cytometry Platform has 1 investors on record on gritt.io and 1 late-stage investors.
When did iQue® Advanced Flow Cytometry Platform last raise funding?
The most recent investment in iQue® Advanced Flow Cytometry Platform recorded on gritt.io was in 2013.
When was iQue® Advanced Flow Cytometry Platform founded?
iQue® Advanced Flow Cytometry Platform was founded in 2006.
What industry is iQue® Advanced Flow Cytometry Platform in?
iQue® Advanced Flow Cytometry Platform operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is iQue® Advanced Flow Cytometry Platform based?
iQue® Advanced Flow Cytometry Platform is headquartered in Albuquerque, United States.